Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Akeso Biopharma

Request full access

A clinical-stage biopharmaceutical company committed to in-house discovery, development and commercialization of first-in-class and best-in-class therapies

Zhongshan, ChinaFounded 2012Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2020

Akeso Biopharma in the Zhongshan ecosystem

Live from Dealroom

The Akeso Biopharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later4 investors entered at this stage

  • Ally Bridge Group
  • ShenZhen GTJA Investment Group
  • Loyal Valley Capital
  • Sino Biopharmaceutical
Employees mapped 119 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 22 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Zhongshan HQ
Book a demo for the full country breakdown

Patents

Estimated portfolio value
$59M

101 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Akeso Biopharma was the backer or acquirer, 2025–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

1 deals across Akeso Biopharma's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Akeso Biopharma's portfolio, mapped.

        Stage
        Period
        1 of 1 deals

        See Akeso Biopharma on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.